Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Positive phase III results for Actiza

Oct. 2, 2003

XMP-629 enters phase I trial for topical treatment of acne

Oct. 2, 2003

Phase II trial of repifermin for chronic venous ulcers does not meet primary endpoint

Sep. 30, 2003

Cytochroma selects drug candidate for treatment of psoriasis

Sep. 26, 2003

New CCR3 antagonist with oral activity in animal model of atopic dermatitis

Sep. 25, 2003

Increased expression of constitutive proteins in burned children treated with oxandrolone

Sep. 23, 2003

IsoTis signs licensing agreement for Allox

Sep. 23, 2003

SBIR grant awarded for clinical trials of rhLF for diabetic foot ulcers

Sep. 22, 2003

Clinical benefits of topical PTH(1-34) cream in chronic plaque psoriasis

Sep. 22, 2003

Novel glucocorticoid agonists and their use

Sep. 18, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....